StreetInsider.com News Articles

Form 8-K MANGOCEUTICALS, INC. For: Aug 19

Fri, 21 Aug 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260821/26962459.html

Form 8-K MANGOCEUTICALS, INC. For: Aug 19

Fri, 21 Aug 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260821/26962459.html

Form 10-Q MANGOCEUTICALS, INC. For: Jun 30

Thu, 13 Aug 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260813/26922877.html

Form 10-Q MANGOCEUTICALS, INC. For: Jun 30

Thu, 13 Aug 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260813/26922877.html

Form 425 MANGOCEUTICALS, INC. Filed by: MANGOCEUTICALS, INC.

Thu, 13 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260813/26921611.html

Form 425 MANGOCEUTICALS, INC. Filed by: MANGOCEUTICALS, INC.

Thu, 13 Aug 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260813/26921611.html

Nuclea Energy agrees to buy Moltex Energy's nuclear technology assets

Thu, 13 Aug 2026 16:07:15 -0400

Nuclea Energy Inc., an advanced nuclear technology company based in Mississauga, Ontario, announced that its wholly owned subsidiary, Nuclea Energy Canada Inc., has entered into a definitive agreement to acquire technology assets from Moltex Energy Limited, which is currently in administration.

The asset acquisition targets intellectual property and development materials associated with Moltex's Stable Salt Reactor-Wasteburner (SSR-W), a 300–500 MWe advanced molten salt fast reactor, and its Waste To Stable Salt (WATSS) spent nuclear fuel recycling process. The portfolio also includes 80 patents across nine patent families and nine pending patents related to the fuel recycling process.

The target portfolio was developed

Nuclea Energy agrees to buy Moltex nuclear technology assets

Thu, 13 Aug 2026 16:05:43 -0400

Nuclea Energy, Inc., the merger partner of Mangoceuticals, Inc. (NASDAQ: MGRX), has signed a definitive agreement to acquire advanced nuclear technology assets from Moltex Energy Limited, which is currently in administration, according to a press release issued by Mangoceuticals.

The transaction, structured principally as an asset acquisition, targets intellectual property and development materials associated with Moltex's Stable Salt Reactor–Wasteburner (SSR-W), a 300–500 MWe molten salt fast reactor, and its Waste To Stable Salt (WATSS) spent nuclear fuel recycling process. The portfolio also includes a FLEX reactor design and a patent portfolio comprising 80 patents across nine patent families, plus nine pending

Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets

Thu, 13 Aug 2026 16:05:00 -0400

The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 million in private investment and public funding from Canada and the U.S. Department of Energy.

Asset-led transaction to add intellectual property and development materials related principally to the SSR-W advanced reactor and WATSS spent nuclear fuel recycling technologies.

DALLAS, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) today announced that its merger partner, Nuclea Energy, Inc. (“Nuclea”), an advanced nuclear technology company headquartered in Mississauga, Ontario, developing the Morpheus

Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets

Thu, 13 Aug 2026 16:05:00 -0400

The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 million in private investment and public funding from Canada and the U.S. Department of Energy.

Asset-led transaction to add intellectual property and development materials related principally to the SSR-W advanced reactor and WATSS spent nuclear fuel recycling technologies.

Nuclea Energy, Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets

Thu, 13 Aug 2026 16:05:00 -0400

The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 million in private investment and public funding from Canada and the U.S. Department of Energy.

Asset-led transaction to add intellectual property and development materials related principally to the SSR-W advanced reactor and WATSS spent nuclear fuel recycling technologies.

Mississauga, Ontario--(Newsfile Corp. - August 13, 2026) - Nuclea Energy Inc. ("Nuclea" or the "Company"), an advanced nuclear technology company headquartered in Mississauga, Ontario, developing the Morpheus microreactor, a lead-cooled, factory-built micro-modular reactor, today announces that its wholly owned subsidiary, Nuclea Energy Canada Inc. ("Nuclea Canada"), has

Nuclea Energy, Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets

Thu, 13 Aug 2026 16:05:00 -0400

The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 million in private investment and public funding from Canada and the U.S. Department of Energy.

Asset-led transaction to add intellectual property and development materials related principally to the SSR-W advanced reactor and WATSS spent nuclear fuel recycling technologies.

Nuclea Energy signs MOU with New Mining Co. for reactor power study

Thu, 06 Aug 2026 07:03:53 -0400

Nuclea Energy Inc., an advanced nuclear technology company based in Mississauga, Ontario, has signed a non-binding memorandum of understanding with New Mining Co., a Miami-based Bitcoin mining infrastructure operator, to evaluate deploying modular reactor technology at New Mining's data center facilities.

According to a press release, the MOU establishes a two-phase evaluation framework. The first phase covers engineering scoping for New Mining's current approximately 30 MWe of operational data center load. The second phase assesses modular expansion toward a cumulative capacity of up to 100 MWe as New Mining's infrastructure grows.

The agreement does not constitute a power purchase agreement, energy offtake

Nuclea Energy signs MOU with New Mining for reactor power study

Thu, 06 Aug 2026 07:01:04 -0400

Nuclea Energy Inc., the merger partner of Mangoceuticals, Inc. (NASDAQ: MGRX), has signed a non-binding memorandum of understanding with New Mining Co. to assess the technical feasibility of deploying modular reactor technology at New Mining's data center facilities.

Under the agreement, the two companies will evaluate co-locating Nuclea's modular power units at or adjacent to New Mining's data centers. The evaluation is structured in two phases: an initial engineering scoping phase covering New Mining's current approximately 30 MWe of operational load, followed by a scalability phase targeting up to 100 MWe of cumulative behind-the-meter capacity.

Nuclea, headquartered in Mississauga, Ontario, will provide

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

Thu, 06 Aug 2026 07:00:00 -0400

MOU will assess the technical feasibility of integrating Nuclea’s modular reactor technology into New Mining’s data center operations, with a phased evaluation path toward a cumulative 100 MWe of behind-the-meter capacity

Dallas, Texas, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) today announced that its merger partner, Nuclea Energy Inc. (“Nuclea”), an advanced nuclear technology company headquartered in Mississauga, Ontario, has signed a non-binding memorandum of understanding (the “MOU”) with New Mining Co. (“New Mining”), a Miami-headquartered provider of high-density digital infrastructure and computing hosting services, to evaluate the

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

Thu, 06 Aug 2026 07:00:00 -0400

Nuclea Energy Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

Thu, 06 Aug 2026 07:00:00 -0400

The MOU will assess the technical feasibility of integrating Nuclea's modular reactor technology into New Mining's data center operations, with a phased evaluation path toward a cumulative 100 MWe of behind-the-meter capacity

Mississauga, Ontario--(Newsfile Corp. - August 6, 2026) - Nuclea Energy Inc. ("Nuclea"), an advanced nuclear technology company headquartered in Mississauga, Ontario, today announced that it has signed a non-binding memorandum of understanding (the "MOU") with New Mining Co. ("New Mining"), a Miami-headquartered provider of high-density digital infrastructure and computing hosting services, to evaluate the technical and structural feasibility of deploying Nuclea's modular reactor technology to serve New Mining's behind-the-meter

Nuclea Energy Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

Thu, 06 Aug 2026 07:00:00 -0400

Form 425 MANGOCEUTICALS, INC. Filed by: MANGOCEUTICALS, INC.

Thu, 06 Aug 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260806/26877404.html

Form 425 MANGOCEUTICALS, INC. Filed by: MANGOCEUTICALS, INC.

Thu, 06 Aug 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260806/26877404.html

Nuclea Energy signs MOU with Utah for microreactor test site

Wed, 05 Aug 2026 16:08:54 -0400

Nuclea Energy USA Inc., a subsidiary of Nuclea Energy Inc., signed a memorandum of understanding with the Utah Office of Energy Development on June 2, 2026, to explore siting a nuclear test reactor at the Utah San Rafael Energy Lab, according to a company statement.

The agreement covers exploration of a test site for Nuclea's Morpheus microreactor, a lead-cooled, graphite-moderated unit designed to scale from approximately 3.5 megawatts electric to 50 megawatts electric. Under the MOU, the two parties will also support engagement with the U.S. Department of Energy and the Nuclear Regulatory Commission, and evaluate pathways for future deployment of

Nuclea Energy signs MOU with Utah for microreactor test site

Wed, 05 Aug 2026 16:08:22 -0400

Nuclea Energy USA Inc., a wholly owned subsidiary of Nuclea Energy Inc. and merger partner of Mangoceuticals, Inc. (NASDAQ: MGRX), has signed a memorandum of understanding with the Utah Office of Energy Development to explore siting a nuclear test reactor at the Utah San Rafael Energy Lab.

The agreement covers exploration of a location for Nuclea's Morpheus microreactor, a lead-cooled, graphite-moderated micro-modular reactor designed to be factory-built and transportable, with a scalable output ranging from approximately 3.5 megawatts electric to 50 megawatts electric. Under the MOU, the parties plan to engage with both the U.S. Department of Energy and the Nuclear

Nuclea Energy signs MOU with Utah for microreactor test site

Wed, 05 Aug 2026 16:08:22 -0400

Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development

Wed, 05 Aug 2026 16:05:00 -0400

The MOU supports exploration of a nuclear test reactor site at the Utah San Rafael Energy Lab and engagement with the U.S. Department of Energy and Nuclear Regulatory Commission to advance the Morpheus microreactor toward demonstration and deployment

Dallas, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) today announced that its merger partner’s wholly owned subsidiary, Nuclea Energy USA Inc. (“Nuclea USA”), has signed a memorandum of understanding (the “MOU”) with the State of Utah Office of Energy Development (“OED”) to explore the siting of a nuclear test

Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development

Wed, 05 Aug 2026 16:05:00 -0400